Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nordic Nanovector ASA ( (DE:8NN) ) has shared an update.
Thor Medical ASA has completed a private placement and retail offering, raising approximately NOK 86.4 million in total. As a result of these transactions, Scatec Innovation AS, a significant shareholder, has increased its holdings to 23.4% of the company’s shares, crossing key ownership thresholds under Norwegian securities law. This development could impact Thor Medical’s shareholder dynamics and market positioning.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier in the radiopharmaceutical industry, focusing on the production of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. The company utilizes a proprietary production process that is environmentally friendly and cost-efficient, without the need for irradiation or nuclear reactors. Thor Medical is based in Oslo, Norway, and is publicly traded on the Oslo Stock Exchange under the ticker ‘TRMED’.
Average Trading Volume: 2,133,987
Current Market Cap: NOK778.2M
For detailed information about 8NN stock, go to TipRanks’ Stock Analysis page.